Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   540,054    

Indirect Shares

   247,533      
Direct Value   $43,092,104    

Indirect Value

   $21,938,850      
Total Shares   787,587      
Total Value   $65,030,954      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
            Keros Therapeutics, Inc. KROS 2024-06-01 200 0    Premium*  
* Premium Members only  

Records found :    853         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 19 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-12-29 4 AS $88.18 $132,270 D/D (1,500) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-12-28 4 AS $88.77 $133,155 D/D (1,500) 297,052 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-05-03 4 S $26.68 $134,266 D/D (5,000) 89,893 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-10-16 4 AS $67.73 $135,450 I/I (2,000) 45,740 0 -
INCY Incyte Corp Director   –       •      –    2017-04-07 4 AB $139.48 $139,480 D/D 1,000 2,177 0 -
INCY Incyte Corp Director   –       •      –    2017-04-13 4 AB $139.66 $139,660 D/D 1,000 3,177 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-07 4 AS $47.04 $141,123 D/D (3,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-05-10 4 OE $14.39 $143,900 D/D 10,000 336,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-10 4 AS $48.03 $144,084 D/D (3,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-04-01 4 OE $6.46 $145,647 I/I 22,546 55,804 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-09-16 4 AS $73.08 $146,163 I/I (2,000) 48,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-11-02 4 AS $97.88 $146,820 D/D (1,500) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-09-04 4 AS $98.16 $147,240 D/D (1,500) 285,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-08 4 OE $9.86 $147,900 D/D 15,000 128,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-14 4 OE $9.86 $147,900 D/D 15,000 183,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-16 4 OE $9.86 $147,900 D/D 15,000 183,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-10-03 4 AS $99.36 $149,040 D/D (1,500) 286,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-01 4 OE $6.46 $149,988 I/I 23,218 56,476 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-10-21 4 AS $75.00 $150,000 I/I (2,000) 46,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-09-14 4 S $37.91 $151,628 D/D (4,000) 177,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-10-31 4 AS $37.68 $151,856 D/D (4,000) 174,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-03-04 4 S $38.00 $152,000 D/D (4,000) 7,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-07-23 4 AS $101.69 $152,535 D/D (1,500) 285,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-03-26 4 OE $12.99 $155,880 I/I 12,000 25,545 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-12-02 4 S $103.97 $155,967 D/D (1,500) 321,424 0 -
  853  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19  20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 19 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us